Answers are grounded in this paper and cite their sources.
Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality worldwide. Objectives: To determine the prevalence of eosinophilia in COPD exacerbation, and to evaluate its association with exacerbation severity. Methods: This cross-sectional study was conducted at the Department of Pulmonology, Indus Hospital and Health Network, Karachi, Pakistan, during April 2024 to September 2024. A total of 141 diagnosed cases of COPD patients were analyzed. Eosinophilia was labeled as a blood eosinophil count ≥ 2%. Stratification analysis was performed to observe the effects of effect modifiers on the prevalence of eosinophilia, applying Chi-square or Fisher's exact test, taking p<0.05 as statistically significant. Results: In a total of 141 patients, 101 (71.6%) were males, and the median age was 62.0 (52.0-71.0) years. Monthly family income was classified as low in 80 (56.7%) patients. Smoking status was ‘never smoked’ in 65 (46.1%), ‘ex-smoker’ in 61 (43.3%), and ‘current smoker’ in 15 (10.6%) patients. Hypertension and diabetes mellitus were reported in 92 (65.2%) and 73 (51.8%) patients. Eosinophilia was identified in 58 (41.1%) patients. Smoking status differed significantly with respect to the prevalence of eosinophilia (p=0.024). Severity of COPD exacerbation differed by eosinophilia status, as increasing severity was significantly associated with eosinophilia (p<0.001). Conclusions: Blood eosinophilia was frequently observed among patients admitted with COPD exacerbation and showed a significant association with smoking status and exacerbation severity.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: